Sarmad Hanif

628 citations
13 papers · 477 indexed · h-index 10
Topics
Pneumonia and Respiratory Infections (5 papers)Bacterial Infections and Vaccines (5 papers)Phytochemicals and Antioxidant Activities (2 papers)

In The Last Decade

Sarmad Hanif

13 papers receiving 459 citations

Peers

Sarmad Hanif
Comparison fields: 5 of 85
  • Molecular Biology 182
  • Biochemistry 107
  • Organic Chemistry 77
  • Pathology and Forensic Medicine 67
  • Plant Science 61
Replace Ramakrishna Vadde with:
Ramakrishna Vadde India
Samir A. Kouzi United States
Sabeeha Ali India
V. Magesh India
Shashanka K. Prasad India
Bayan Al-Dabbagh United Arab Emirates
Ahmed I. Abd El Maksoud Egypt
Sushma R. Gundala United States
Islam Rady United States
Rajesh Naithani United States
Sarmad Hanif relative to Ramakrishna Vadde India Ramakrishna Vadde's profile →
Citations per field
00.5×1.5×
Ramakrishna Vadde · 1×
Citations per year

Countries citing papers authored by Sarmad Hanif

Since Specialization
Citations

This map shows the geographic impact of Sarmad Hanif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarmad Hanif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarmad Hanif more than expected).

Fields of papers citing papers by Sarmad Hanif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarmad Hanif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarmad Hanif. The network helps show where Sarmad Hanif may publish in the future.

Co-authorship network of co-authors of Sarmad Hanif

This figure shows the co-authorship network connecting the top 25 collaborators of Sarmad Hanif. A scholar is included among the top collaborators of Sarmad Hanif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarmad Hanif. Sarmad Hanif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 42
2 7
3 5
4 11
5 4
6 32
7 43
8 40
9 41
10 39
11 33
12 32
13 148

About Sarmad Hanif

Sarmad Hanif is a scholar working on Microbiology, Business and International Management and Biochemistry, having authored 13 papers that have together received 477 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (5 papers), Bacterial Infections and Vaccines (5 papers) and Phytochemicals and Antioxidant Activities (2 papers). The work is most often cited by research in Biochemistry (107 citations), Toxicology (48 citations) and Geriatrics and Gerontology (38 citations). Sarmad Hanif has collaborated with scholars based in India, United States and Saudi Arabia. Frequent co-authors include Asfar S. Azmi, S.M. Hadi, Harish S. Bhat, Uzma Shamim, Mohammad Fahad Ullah, Sheikh M. Hadi, Mohd Fahad Ullah, Deepti Singh, Nitin Kumar and K. Sree Kumar. Their work appears in journals such as FEBS Letters, Journal of Cellular Physiology and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026